Impact of ABO incompatibility on allogeneic peripheral blood progenitor cell transplantation after reduced intensity conditioning.
about
ABO-Mismatched Allogeneic Hematopoietic Stem Cell TransplantationClinical observation of factors in the efficacy of blood component transfusion in patients following hematopoietic stem cell transplantation.Prevention of pure red cell aplasia after major or bidirectional ABO blood group incompatible hematopoietic stem cell transplantation by pretransplant reduction of host anti-donor isoagglutininsOutcomes after major or bidirectional ABO-mismatched allogeneic hematopoietic progenitor cell transplantation after pretransplant isoagglutinin reduction with donor-type secretor plasma with or without plasma exchange.Red blood cell-incompatible allogeneic hematopoietic progenitor cell transplantation.Transfusion support issues in hematopoietic stem cell transplantation.Development of enhancing agglutination reaction using gold nanoparticle for pre-transfusion testing.ABO incompatibility does not influence transfusion requirements in patients undergoing single-unit umbilical cord blood transplantation.Transfusion policy: when to stop the use of extremely rare blood for an allogeneic hematopoietic progenitor cell transplant recipient with a history of red cell alloimmunization.ABO incompatibility in mismatched unrelated donor allogeneic hematopoietic cell transplantation for acute myeloid leukemia: A report from the acute leukemia working party of the EBMT.The impact of donor type and ABO incompatibility on transfusion requirements after nonmyeloablative haematopoietic cell transplantation.ABO blood group incompatibility as an adverse risk factor for outcomes in patients with myelodysplastic syndromes and acute myeloid leukemia undergoing HLA-matched peripheral blood hematopoietic cell transplantation after reduced-intensity conditionIs ABO mismatch another risk factor for allogeneic hematopoietic stem cell transplantation in pediatric thalassemic patients?ABO Incompatibility and Hematopoietic Stem Cell Transplantation OutcomesLack of effect of donor-recipient ABO mismatching on outcome following allogeneic hematopoietic stem cell transplantation.Prophylactic red blood cell exchange for ABO-mismatched hematopoietic progenitor cell transplants.Donor-to-Recipient ABO Mismatch Does Not Impact Outcomes of Allogeneic Hematopoietic Cell Transplantation Regardless of Graft Source.Infusion hemolysis after pediatric major ABO-mismatched bone marrow transplant: Comparison of two red blood cell depletion techniques.ABO blood group antigen mismatch has an impact on outcome after allogeneic peripheral blood stem cell transplantation.Impact of ABO blood group mismatch in alemtuzumab-based reduced-intensity conditioned haematopoietic SCT.Major ABO-incompatible BMT: isohemagglutinin reduction with plasma exchange is safe and avoids graft manipulation.Impact of nonmyeloablative conditioning regimens on the occurrence of pure red cell aplasia after ABO-incompatible allogeneic haematopoietic stem cell transplantation.Transfusions after nonmyeloablative or reduced-intensity conditioning regimens.
P2860
Q26750395-FF2B98FC-28BC-4C48-B338-B8E2192071EDQ34304959-13B2E9FE-88C3-44CC-B715-AA2761516865Q37082695-DEF7DFF1-C60E-45EA-8B9C-3D5364E15524Q37919167-7956A053-9104-470A-8EDB-59957F003B61Q37928443-F980D8D2-CDD2-449D-8611-DFAE793E713EQ38287605-3D3156C0-D376-4D95-9A7C-6442C1FC31FDQ38809708-509D2B4A-F453-457A-9EE1-1391B8ACD762Q39232815-B26EFEC3-EE10-421D-BD50-22EB58F46E89Q40218366-7BEFC62C-FA1E-4B30-A7F5-9AE441E7C3E5Q40229220-023D8A4A-7D30-4DEF-A65C-094F6B9E3EC0Q40359224-6428DB9F-5C69-4E67-A0CB-D3A56578CA67Q40456337-F4608AA8-F205-465E-839B-0E3C4B3A75EDQ40756603-48E0C549-3FFA-4ECB-A46B-2F84F5A6D05DQ41553547-3CCD0EFA-7A15-4221-A87C-4F6AF68864F9Q44066275-5BE0011A-D6E0-4F66-A83A-C99466F44FFFQ46168868-98E3EACB-347D-43D2-939D-F30DDCB1D411Q47431505-8E2E2D62-88AC-4F04-8391-BE77104FFC7FQ48344687-03F2EC44-6F85-4444-A512-940FA9B49522Q50225112-C1F59368-07B0-4071-AE39-A8F4C26800F7Q50448290-BA309585-853C-486B-B175-F283DE94E8FFQ50496576-23BF8F71-DDC9-4957-90E9-C84E8BF7718BQ50710888-E0FCC721-2D1C-4E05-A7DE-4D31398C2F8BQ53593916-D011E899-D632-414C-8E84-9325994C30D0
P2860
Impact of ABO incompatibility on allogeneic peripheral blood progenitor cell transplantation after reduced intensity conditioning.
description
2004 nî lūn-bûn
@nan
2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Impact of ABO incompatibility ...... educed intensity conditioning.
@ast
Impact of ABO incompatibility ...... educed intensity conditioning.
@en
type
label
Impact of ABO incompatibility ...... educed intensity conditioning.
@ast
Impact of ABO incompatibility ...... educed intensity conditioning.
@en
prefLabel
Impact of ABO incompatibility ...... educed intensity conditioning.
@ast
Impact of ABO incompatibility ...... educed intensity conditioning.
@en
P2093
P2860
P1433
P1476
Impact of ABO incompatibility ...... educed intensity conditioning.
@en
P2093
Adelaida Ramos
Angel Remacha
Carmen Canals
Clara Martínez
Concepción Pastoret
Eduardo Muñiz-Díaz
Imma Moreno
Jorge Sierra
Marina Arilla
P2860
P304
P356
10.1111/J.1537-2995.2004.04106.X
P577
2004-11-01T00:00:00Z